Urology Times Podcasts3 Nov 2025

First Assist: Precision in Radiation for Localized Prostate Cancer, with Pretesh Patel, MD

In this episode of First Assist: GU Oncology Unpacked, host Taylor Goodstein, MD, sits down with Pretesh Patel, MD, associate professor of radiation oncology at Emory University, for an in-depth conversation about modern approaches to radiation therapy in prostate cancer. Patel breaks down complex terminology, evolving technologies, and patient-centered strategies for delivering precise, effective, and individualized radiation care.

The discussion begins with an overview of radiation modalities — from external beam radiation (IMRT, SBRT/SABR, proton therapy) to brachytherapy (LDR and HDR). Patel explains how imaging advances, fiducial markers, and rectal spacers have made treatments safer and more accurate, and how hypofractionation—fewer sessions with higher daily doses—has become standard for many prostate cancer patients.

Goodstein and Patel explore how image guidance and adaptive radiation planning have revolutionized precision, even allowing real-time treatment plan adjustments. They also discuss patient experience, outlining what to expect from fiducial placement to simulation scans and the short, painless daily treatments that define SBRT.

Patel highlights how biologic factors like the prostate’s low alpha-beta ratio make it especially responsive to higher-dose, shorter-course radiation. He details patient-specific considerations—such as urinary function, prostate size, and median lobe anatomy — that help determine whether external beam, brachytherapy, or combination therapy is best.

As the conversation deepens, Patel outlines treatment paradigms for different risk groups:

Low-risk: active surveillance preferred; if treated, short-course SBRT or brachytherapy without ADT

Favorable intermediate-risk: radiation alone often sufficient

Unfavorable intermediate-risk: radiation plus 4 to 6 months of ADT, guided by genomic and AI-based classifiers like Decipher and ArteraAI.

High-risk: combination approaches—brachytherapy boost plus external beam—and longer-term ADT (18 to 36 months).

Patel shares insight into ADT decision-making, comparing GnRH agonists and antagonists, discussing cardiac considerations, flare effects, and recovery timelines.

The episode concludes with an honest conversation about toxicities and survivorship—urinary and sexual function, bowel changes, and the dramatic reduction in rectal injury seen with modern imaging and rectal spacers. Patel emphasizes the importance of shared decision-making, balancing cancer control with quality of life, and integrating patient priorities into every step of radiation planning.

Chapters
00:22 Defining radiation in prostate cancer
6:44 IGRT guidance
12:30 The patient's experience with radiation
21:27 When hypofractionation is not recommended
28:10 Risk groups
35:15 Timing of ADT
40:10 High-risk prostate cancer
52:31 Timing of sexual dysfunction

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(214)

Pearls & Perspectives: Patient Expectations, Physician Autonomy, and Life Beyond Surgery, With Andrew T. Cohen, MD, FACS

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, and plastic surgeon Andrew T. Cohen, MD, FACS, discuss managing patient expectations and the importance of cultivating balance outside ...

12 Aug 39min

The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH

In this episode of The UroOnc Minute, Mark D. Tyson, II, MD, MPH, joins host Adam Weiner, MD, to discuss the importance of BCG maintenance therapy in NMIBC and share strategies for navigating treatmen...

12 Aug 13min

Pearls & Perspectives: Wearable Technology and the Future of Sexual Health, With Elliot Justin, MD

Host Amy Pearlman, MD, and guests Larry Lipshultz, MD, and Elliot Justin, MD, explore the potential of wearable technology to advance the diagnosis, monitoring, and optimization of sexual health for b...

12 Aug 15min

Pearls & Perspectives: From Prostate Cancer Diagnosis to Patient Advocacy, with Gabe Canales

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, is joined by male reproductive specialist Larry Lipshultz, MD, and patient advocate Gabe Canales for a candid conversation about prosta...

12 Aug 15min

The UroOnc Minute: Optimizing Patient Follow-Up in Urologic Oncology, With Jason Hafron, MD

In this episode of The UroOnc Minute, host Adam Weiner, MD, is joined by Jason Hafron, MD, to discuss how data-driven pathways and patient follow-up systems can improve quality and outcomes in urologi...

24 Juli 12min

Pearls & Perspectives: Understanding the Long-Term Health Effects of Military Exposures, With Shane Kronstedt, MD

Host Amy Pearlman, MD, and Larry Lipshultz, MD, speak with Shane Kronstedt, MD, about research on the long-term urologic effects of military exposures and how these findings may help improve care for ...

22 Juli 5min

First Assist: Early Cystectomy in Non–Muscle Invasive Bladder Cancer, with Matvey Tsivian, MD

In this episode of First Assist: GU Oncology Unpacked, host Taylor Goodstein, MD, is joined by Matvey Tsivian, MD, to discuss how patient selection, staging, and quality-of-life considerations influen...

15 Juli 49min

Pearls & Perspectives: The Present and Future of Male Fertility Testing, With Dolores J. Lamb, PhD

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, is joined by Larry I. Lipshultz, MD, and Dolores J. Lamb, PhD, to discuss the evolving role of semen analysis, laboratory diagnostics, ...

15 Juli 18min